Strongyloidiasis in the Northern Territory
- 1 July 1993
- journal article
- research article
- Published by AMPCo in The Medical Journal of Australia
- Vol. 159 (2) , 88-90
- https://doi.org/10.5694/j.1326-5377.1993.tb137741.x
Abstract
Objective To describe the clinical and laboratory features and management of Strongyloides stercoralis infection in the Top End of the Northern Territory. Design A 12‐month retrospective review of clinical records of patients confirmed on stool microscopy to be infected with S. stercoralis. Setting The Royal Darwin Hospital (RDH), a 300‐bed referral hospital servicing the tropical areas of the Northern Territory, which have a population of 120 000, 21% of which is Aboriginal. Results Potentially pathogenic gastrointestinal parasites were identified in 205 patients over the 12 months. Of these, 68 patients had strongyloidiasis — 64 were Aboriginal, three were Caucasian and one was of New Guinean origin. Thirty‐seven (54%) were under five years of age. Patients came from all regions served by RDH, including urban Darwin. Seventy‐five per cent of adults had chronic underlying disease and 80% of children under five years old were below 80% of standard weight for age. Gastrointestinal symptoms were absent in 28%; occasionally, severe disease occurred. Eosinophilia with greater than 0.7 x 109 cells/L was present in 57% of patients. Only 57% of cases were treated with thiabendazole. Conclusion In the Top End of the Northern Territory, Strongyloides infection is endemic in Aboriginal communities, but also occasionally occurs in non‐Aboriginal people. It is likely that the infection is frequently not recognised. Current community‐based anthelmintic regimens have succeeded in reducing the prevalence of hookworm infection, but strongyloidiasis still appears to be a prevalent condition. The possibility of hyper‐infection or disseminated strongyloidiasis in immunocompromised patients such as renal transplant recipients and people infected with the human immunodeficiency virus needs consideration in this endemic area. The interaction in northern Australia of S. stercoralis with human T‐lymphotropic virus type I and with undernutrition warrants further study.Keywords
This publication has 20 references indexed in Scilit:
- Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppressionThe American Journal of Medicine, 1992
- Adult T‐cell leukaemia lymphoma in an AborigineAustralian and New Zealand Journal of Medicine, 1991
- Disseminated strongyloidiasis in AIDSAIDS, 1991
- Diagnosis of Strongyloides and hookworm infections: comparison of faecal and duodenal fluid microscopyTransactions of the Royal Society of Tropical Medicine and Hygiene, 1990
- Human eosinophilic enteritis caused by dog hookworm Ancylostoma caninumPublished by Elsevier ,1990
- MEBENDAZOLE AND ALBENDAZOLE FOR INFANTSThe Pediatric Infectious Disease Journal, 1990
- Global Prevalence of Strongyloidiasis: Critical Review with Epidemiologic Insights into the Prevention of Disseminated DiseaseClinical Infectious Diseases, 1989
- STRONGYLOIDES STERCORALIS AS CANDIDATE CO-FACTOR FOR HTLV-I-INDUCED LEUKAEMOGENESISThe Lancet, 1987
- HIGH INCIDENCE OF HTLV ANTIBODY IN CARRIERS OF STRONGYLOIDES STERCORALISThe Lancet, 1984
- Strongyloidiasis in Allied ex-prisoners of war in south-east AsiaBMJ, 1980